Pfenex Lands $24,000,000 New Funding Round

  • Feed Type
  • Date
    12/10/2009
  • Company Name
    Pfenex
  • Mailing Address
    5501 Oberlin Drive San Diego, CA 92121
  • Company Description
    Headquartered in San Diego, California, Pfenex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company’s core technology, Pfenex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfenex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.
  • Website
    http://www.pfenex.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $24,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Dow Venture Capital
  • Venture Investor
    Signet Healthcare Partners

By posting a comment, you agree to our terms and conditions.